Anyone who has had to inject glucagon during a crisis would gladly reach for something easier to use, if it were available, but only if that alternative were just as effective in staving off hypoglycemia. Locemia Solutions has been developing an intranasal glucagon that offers the possibility of eliminating glucagon injections, and the company has announced a string of positive results in key safety trials for its product in 2015.

Read more